Phase II results of dovitinib (TKI258) in patients with metastatic renal cell cancer

  1. Escudier, B.
  2. Grünwald, V.
  3. Ravaud, A.
  4. Ou, Y.-C.
  5. Castellano, D.
  6. Lin, C.-C.
  7. Gschwend, J.E.
  8. Harzstark, A.
  9. Beall, S.
  10. Pirotta, N.
  11. Squires, M.
  12. Shi, M.
  13. Angevin, E.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265 1078-0432

Argitalpen urtea: 2014

Alea: 20

Zenbakia: 11

Orrialdeak: 3012-3022

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-13-3006 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak